|Keyword||CPC||PCC||Volume||Score||Length of keyword|
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management.What does collegium’s Share Repurchase Program mean for colcollegium pharmaceutical?
Collegium Pharmaceutical, Inc. (NasdaqGS:COLL) announces a share repurchase program. Under the program, the company will repurchase up to $100 million worth of its own shares. The company plans to utilize existing cash on hand to fund the share repurchase program.Is Coll's management growing profits?
Growing Profit Margin: COLL's current net profit margins (31.8%) are higher than last year (5.7%). Earnings Trend: COLL has become profitable over the past 5 years, growing earnings by 66.6% per year. Accelerating Growth: COLL's earnings growth over the past year (488.4%) exceeds its 5-year average (66.6% per year).